ESSA Pharma Inc. — Investor Relations & Filings
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer. The company's core strategy is to develop novel therapies that target the N-terminal domain (NTD) of the androgen receptor (AR). This approach represents a distinct mechanism of action compared to existing treatments that target the ligand-binding domain of the AR. Its lead clinical candidate, EPI-7386, is an investigational oral drug designed to inhibit AR activity and is being developed for patients with castration-resistant prostate cancer (CRPC), including those whose disease has become resistant to current standard-of-care therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-11-17 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 15-12G | 2025-10-28 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12852931 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 12852932 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852935 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852934 | 15-12G | 2025-10-28 | English | ||
| 12852933 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852936 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852937 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852938 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852939 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852940 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852941 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852942 | POS AM | 2025-10-15 | English | ||
| 12852943 | S-8 POS | 2025-10-15 | English | ||
| 12852944 | S-8 POS | 2025-10-15 | English | ||
| 12852945 | S-8 POS | 2025-10-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Fuso Pharmaceutical Industries,Ltd.
Develops and manufactures pharmaceuticals, focusing on infu…
|
4538 | JP | Manufacturing |
|
FUTURA MEDICAL PLC
Pharmaceutical company developing topical gel formulations …
|
FUM | GB | Manufacturing |
|
FutureChem Co., Ltd.
Develops radiopharmaceuticals and synthesis equipment for d…
|
220100 | KR | Manufacturing |
|
Future Medicine Co., Ltd.
Develops nucleoside-based synthetic drugs for antiviral and…
|
341170 | KR | Manufacturing |
|
G2GBIO, Inc.
Develops sustained-release drugs using a long-acting inject…
|
456160 | KR | Manufacturing |
|
Gabather AB
Develops therapeutics for CNS disorders by targeting the GA…
|
GABA | SE | Manufacturing |
|
GABY Inc.
Produces, markets, and retails cannabis and hemp-derived we…
|
GABY | CA | Manufacturing |
|
Gain Therapeutics, Inc.
Develops allosteric small molecule therapies using an AI dr…
|
GANX | US | Manufacturing |
|
Galapagos NV
A biotechnology company focused on a rapid, decentralized c…
|
GLPG | BE | Manufacturing |
|
Galaxy Medicare Limited
Produces and distributes pharmaceutical products, generics,…
|
GML | IN | Manufacturing |
ESSA Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35249/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35249 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35249 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35249 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35249}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ESSA Pharma Inc. (id: 35249)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.